RecruitingPhase 1NCT03460977
A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Sponsor: Pfizer
Oklahoma City, OK · +43 more sites
Prostate Cancer clinical trials in Oklahoma City, OK
12 recruiting prostate cancer studies with a site in Oklahoma City, OK.
All trials in Oklahoma City, OK · All Prostate Cancer trials
RecruitingPhase 3NCT07028853
This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide Will Work Better Than Taking Enzalutamide Alone in Participants With mCSPC Who Are ARPI naïve.
Sponsor: Pfizer
Oklahoma City, OK · +125 more sites
RecruitingPhase 3NCT07200830
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
Sponsor: Alliance for Clinical Trials in Oncology
Oklahoma City, OK · +137 more sites
RecruitingPhase 3NCT07213674
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
Sponsor: Amgen
Oklahoma City, OK · +44 more sites
RecruitingPhase 3NCT04423211
Treating Prostate Cancer That Has Come Back After Surgery With Apalutamide and Targeted Radiation Based on PET Imaging
Sponsor: ECOG-ACRIN Cancer Research Group
Oklahoma City, OK · +339 more sites
RecruitingPhase 1 / Phase 2NCT06751329
A Study of DM002 in Patients With Advanced Solid Tumors
Sponsor: Xadcera Biopharmaceutical (Suzhou) Co., Ltd.
Oklahoma City, OK · +3 more sites
RecruitingPhase 3NCT06592924
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
Sponsor: Canadian Cancer Trials Group
Lawton, OK · Oklahoma City, OK · +372 more sites
RecruitingPhase 3NCT06470243
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
Sponsor: SWOG Cancer Research Network
Oklahoma City, OK · +173 more sites
RecruitingPhase 1NCT06999187
A Study of DR-0202 in Patients With Locally Advanced or Metastatic, Relapsed or Refractory Carcinomas
Sponsor: Dren Bio
Oklahoma City, OK · +9 more sites
RecruitingPhase not listedNCT07014618
Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer
Sponsor: University of Oklahoma
Oklahoma City, OK
RecruitingNot applicableNCT07055165
Connect2Care: Prostate Cancer Education and Screenings for African American Men
Sponsor: University of Oklahoma
Oklahoma City, OK
RecruitingPhase 1NCT05107674
A Study of NX-1607 in Adults With Advanced Malignancies
Sponsor: Nurix Therapeutics, Inc.
Oklahoma City, OK · +9 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.